Concentra Group Holdings Parent, Inc.

Concentra Group Holdings Parent, Inc.

CON
Concentra Group Holdings Parent, Inc.US flagNew York Stock Exchange
34.47
USD
-0.04
- -
4.41BMarket Cap
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
13.68
13.62
14.52
16.64
16.9
18.01
Basic EPS, GAAP
1.65
1.32
1.42
1.46
1.3
1.56
Free Cash Flow per Basic Share
1.93
1.8
1.3
1.84
1.54
2.11
Dividend per Share
- -
- -
- -
13.52
0.25
0.25
Book Value per Share
- -
7.69
9.13
2.15
3.06
3.73
Tangible Book Value per Share
- -
-3.95
-2.36
-9.08
-10.33
-9.66
Basic Weighted Avg Shares
127
127
127
114
128
127
Sales/Revenue/Turnover
1,732
1,724
1,838
1,900
2,163
2,287
Operating Margin (%)
17.62
14.99
15.65
16.04
15.44
16.39
Depreciation Expense
82
74
73
67
76
80
Net Income, GAAP
209
167
180
167
166
199
Effective Tax Rate (%)
21.6
23.41
23.86
25.71
22.78
23.15
Profit Margin (%)
12.06
9.67
9.79
8.76
7.69
8.69
Working Capital
- -
5
20
130
46
139
LT Debt
- -
967
831
1,866
2,007
2,044
Total Equity
- -
996
1,177
299
420
506
Return on Invested Capital (%)
- -
19.45
10.63
10.44
10.8
11.07
Return on Capital (%)
- -
18.22
10.15
9.83
10.24
10.56
Return on Common Equity (%)
- -
34.26
16.91
23.27
49.75
48.49

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
95
99
100
LT Borrowings
1,564
1,562
1,561
LT Finance Leases
444
461
483
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
129
128
128
Market Capitalization
2,532
2,745
3,807

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
383
404
506
Cash, Cash Equivalents & STI
80
62
158
Accounts Receivable, Net
258
297
300
Inventories
- -
- -
- -
Total Current Liabilities
337
321
368
Payables & Accruals
193
172
217
ST Debt
95
99
100
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
40.74%
Free Cash Flow
- -
- -
-6.32%
Net Income, GAAP
- -
- -
-0.08%
Sales/Revenue/Turnover
- -
- -
13.85%
Total Cash Common Dividend
- -
- -
-97.92%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
468
478
490
465
1,900
2025
501
551
573
539
2,163
2026
570
606
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.39
0.41
0.37
0.17
1.46
2025
0.3
0.35
0.38
0.27
1.3
2026
0.4
0.52
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
12.65
0.06
13.52
2025
- -
0.13
0.06
0.06
0.25
2026
0.06
0.06
- -
- -
- -

Company Description

CEO
William Keith Newton
Full Time Employees
9,983
Sector
Healthcare
Industry
Medical - Care Facilities
Address
5080 Spectrum Drive Addison TX United States of America 75001
IPO Date
Jul 25, 2024
Business
Concentra Group Holdings Parent, Inc. (NYSE: CON) operates as the largest provider of occupational health services in the United States, delivering comprehensive workers' compensation injury care, including primary injury treatment, physical therapy, and return-to-duty examinations; employer services such as pre-placement physical exams, medical surveillance, drug and alcohol testing, and job-specific testing; onsite health clinics; and telemedicine solutions to improve workforce health for employers across various industries. The company, founded in 1979 and headquartered in Addison, Texas, maintains nearly 520 medical centers and over 130 onsite clinics across more than 40 states, serving over 50,000 patients daily through 11,000 colleagues and affiliated physicians. In January 2025, Concentra signed a definitive agreement to acquire Nova Medical Centers, a Houston-based occupational health provider, for $265 million, with the transaction expected to close in the first quarter of 2025 following regulatory approvals, enhancing its service capabilities and market leadership; the company also reported preliminary 2024 revenue of approximately $1.90 billion and provided raised 2025 financial guidance incorporating the Nova acquisition.

Company News

  • 3 Stocks to Add to Your Portfolio After Recent Broker Rating Upgrades

  • Contrasting Concentra Group Holdings Parent (NYSE:CON) and Amarantus Bioscience (OTCMKTS:AMBS)

  • CON vs. MEDP: Which Stock Should Value Investors Buy Now?

  • Concentra Group (CON) is a Great Momentum Stock: Should You Buy?

  • Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health

  • Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health

  • Concentra Strengthens Workforce Health Access in Minnesota Through Acquisition

  • Concentra Strengthens Workforce Health Access in Minnesota Through Acquisition

  • CON or MEDP: Which Is the Better Value Stock Right Now?

  • Concentra Group Holdings Parent, Inc. (CON) Hit a 52 Week High, Can the Run Continue?

  • Concentra to Present at Upcoming Investor Conferences

  • Concentra Group Holdings Parent Q2 Earnings Call Highlights

  • Concentra Group Holdings Parent, Inc. (CON) Q2 2026 Earnings Call Transcript

  • Concentra Group (CON) Q2 Earnings and Revenues Surpass Estimates

  • CON EDISON REPORTS 2026 SECOND QUARTER EARNINGS

  • Concentra Group Holdings Parent, Inc. Announces Results For Its Second Quarter Ended June 30, 2026 and Raises FY 2026 Guidance

  • Concentra Group Holdings Parent (CON) Projected to Release Earnings on Thursday

  • Concentra Group (CON) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

  • Concentra Group Holdings Parent, Inc. $CON Shares Sold by Bank of New York Mellon Corp

  • Are Medical Stocks Lagging Concentra Group Holdings Parent, Inc. (CON) This Year?